Targeting the cardiovascular system with sitagliptin improves diastolic cardiac function but does not improve cardiorespiratory fitness in adults with type 2 diabetes

BACKGROUND. People with type 2 diabetes mellitus (T2D) have preclinical cardiac and vascular dysfunction that predicts low cardiorespiratory fitness (CRF). CRF is a powerful predictor of cardiovascular mortality, a primary concern in T2D management. Glucagon-like pepetide-1 (GLP-1) augments cardiova...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Diabetes Complications
Autors principals: Scalzo, Rebecca L., Rafferty, Deirdre, Schauer, Irene, Huebschmann, Amy G., Cree-Green, Melanie, Reusch, Jane E.B., Regensteiner, Judith G.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7278036/
https://ncbi.nlm.nih.gov/pubmed/31182338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdiacomp.2019.05.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars